NCT00249093View on ClinicalTrials.gov

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2007

Conditions
COPD
Interventions
DRUG

oxygen

Trial Locations (1)

1485

Glittreklinikken, Hakadal

All Listed Sponsors
collaborator

The norwegian association for heart and lung patients

UNKNOWN

lead

LHL Helse

OTHER

NCT00249093 - Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT | Biotech Hunter | Biotech Hunter